Sulderm1%

Sulderm is a topical antifungal medicine indicated for the treatment of certain superficial fungal (dermatophyte and yeast) infections of the skin. Established/labeled uses include:

• Tinea pedis (athlete's foot)
• Tinea cruris (jock itch)
• Tinea corporis (ringworm)
• Cutaneous candidiasis (yeast infection of the skin)

Some formulations of Sulderm are also used for tinea (pityriasis) versicolor, a superficial yeast infection caused by Malassezia species. Sulderm is intended for external, topical use on the skin only and is not indicated for infections of the nails, scalp, or mucous membranes.

Each formulation of Sulconazole Nitrate contains sulconazole nitrate as the active ingredient, typically formulated as a 1% w/w topical cream, lotion, or solution in a suitable dermatological base. Sulconazole Nitrate should be used strictly according to the strength and formulation prescribed by a physician or dispensed by a pharmacist.

Sulderm is a synthetic imidazole-derivative antifungal agent used for topical (on-the-skin) treatment of superficial fungal infections. It has broad-spectrum activity against dermatophytes (such as Trichophyton, Microsporum, and Epidermophyton species) as well as certain yeasts, including Candida and Malassezia furfur. Sulderm is available as a topical cream and solution for external application to affected areas of the skin.

Sulderm belongs to the imidazole class of antifungal agents, a subgroup of topical antifungals used for dermatological (skin) fungal infections.

Sulconazole Nitrate is an imidazole antifungal that acts primarily by inhibiting the fungal cytochrome P450-dependent enzyme 14-alpha-demethylase, which is required to convert lanosterol to ergosterol, the main sterol component of the fungal cell membrane. This inhibition depletes ergosterol and allows accumulation of toxic methylated sterol precursors, disrupting the structure and function of the fungal cell membrane. At higher concentrations, Sulconazole Nitrate may also exert direct fungicidal effects by damaging the cell membrane directly.

Following topical application, systemic absorption of Sulconazole Nitrate through intact skin is minimal, and the drug acts predominantly at the site of application.

Sulderm is for external (topical) use on the skin only.

• Clean and dry the affected area before application.
• Apply a thin layer of Sulderm cream or solution and gently rub in.
• Wash hands after application unless the hands are the area being treated.
• Avoid contact with the eyes, nose, mouth, and other mucous membranes.
• Do not apply occlusive dressings/bandages over the area unless directed by a physician.

Because Sulderm is applied topically and systemic absorption is minimal, clinically significant drug-drug interactions are uncommon. No well-established, clinically significant systemic drug interactions have been documented for Sulderm when used as directed. Concurrent use of other topical products (including other topical antifungals, corticosteroids, or irritant skin preparations) on the same area may increase local irritation and should be discussed with a physician or pharmacist.

Adverse effects of Sulderm are generally mild, local, and transient. The most commonly reported reactions include:

• Burning or stinging sensation at the application site
• Itching
• Local skin irritation or redness (erythema)

These effects are usually mild and resolve without stopping treatment. If severe irritation, blistering, or signs of an allergic reaction (e.g., rash, swelling) occur, discontinue Sulderm and consult a physician (see Contraindications).

Pregnancy: Data on the use of Sulderm in human pregnancy are limited. As with other topical antifungals, systemic absorption is low, but Sulderm should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus. Consult a physician before use.

Lactation: It is not known whether topically applied Sulderm passes into breast milk in clinically significant amounts. Caution is advised; avoid application directly on or near the breast/nipple area, and consult a physician before use while breastfeeding.

Sulderm is for external use only. Observe the following precautions:

• Avoid contact with the eyes, nose, mouth, and other mucous membranes; if accidental contact occurs, rinse thoroughly with water.
• Use Sulderm for the full course/duration prescribed by the physician, even if symptoms improve within the first few days, to reduce the chance of the infection returning.
• Apply Sulderm exactly as prescribed by your physician; do not stop, extend, skip applications, or share this medicine with others without medical advice.
• If there is no improvement within 2-4 weeks, or if symptoms worsen, spread, or recur frequently, stop use and seek medical evaluation, as this may indicate a different or resistant infection.
• Do not apply Sulderm to open wounds or severely broken skin unless directed by a physician.
• Local burning, itching, or irritation may occur at the application site (see Side Effects).

Topical overdose of Sulderm is unlikely to cause serious systemic toxicity due to minimal skin absorption; excessive application may increase local irritation, redness, or burning. If Sulderm is accidentally ingested (swallowed) or if a large area is treated excessively, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pediatric use: See Pediatric Uses.

Elderly: No specific dose adjustment is generally required for elderly patients using Sulderm topically; use as directed and monitor for local skin reactions, as elderly skin may be more sensitive.

Renal/Hepatic impairment: Because systemic absorption of topical Sulderm is minimal, specific dose adjustment for renal or hepatic impairment is not established as necessary; use with routine medical guidance.

Duration of treatment with Sulderm depends on the site and type of infection: typically about 3 weeks for tinea cruris and tinea corporis, and up to 4 weeks for tinea pedis. The full prescribed duration should be completed even if symptoms resolve earlier, to help prevent recurrence.

Imidazole antifungals; Topical antifungal agents.

Sulconazole Nitrate works by inhibiting fungal 14-alpha-demethylase, blocking conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. Reduced ergosterol and accumulation of toxic sterol intermediates weaken the fungal cell membrane, ultimately leading to increased membrane permeability, growth inhibition (fungistatic effect), and, at higher concentrations, fungal cell death (fungicidal effect).

C

The safety and efficacy of Sulderm in pediatric patients below 12 years of age have not been well established in controlled studies. When used in children, Sulderm should be applied under medical supervision, using the smallest effective amount for the shortest necessary duration, and with close observation for local skin reactions.